4.5 Article

IκB kinase is an essential component of the Tp12 signaling pathway

Journal

MOLECULAR AND CELLULAR BIOLOGY
Volume 24, Issue 13, Pages 6040-6048

Publisher

AMER SOC MICROBIOLOGY
DOI: 10.1128/MCB.24.13.6040-6048.2004

Keywords

-

Funding

  1. NCI NIH HHS [T32 CA060395, 5T32CA60395-10] Funding Source: Medline
  2. NIAID NIH HHS [1 R01 AI057555, R01 AI057555] Funding Source: Medline
  3. NCHHSTP CDC HHS [U62 PS001145] Funding Source: Medline
  4. ALLCDC
  5. NCHHSTP [1U62PS001145-01] Funding Source: Federal RePORTER
  6. ALLCDC
  7. NCHHSTP [554634] Funding Source: Federal RePORTER

Ask authors/readers for more resources

IkappaB kinase (IKK), a key regulator of immune and inflammatory responses, is known as an effector kinase mediating activation of the transcription factor NF-kappaB. Whether IKK also participates in other signaling events is not known. Here we show that IKK serves as an essential component of a signaling pathway that involves activation of the Tpl2 kinase and its downstream targets, MEK1 and ERK. Inhibition of IKKbeta in macrophages eliminates Tpl2 activation and ERK phosphorylation induced by lipopolysaccharide and tumor necrosis factor alpha. Using IKK-deficient murine fibroblasts, we further demonstrate that IKKbeta, but not IKKalpha, is required for Tpl2 activation. Moreover, this novel function of IKKbeta appears to involve phosphorylation and degradation of the Tpl2 inhibitor NF-kappaB1/p105. These findings suggest that IKKbeta exerts its immune-regulatory functions by targeting different downstream signaling pathways.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available